Abstract
Swallowing is an important developmental process for human life. It requires the cooperation of the mouth, pharynx, and esophagus for successful completion. Esophageal dysphagia, or difficult swallowing, can be the result of behavioral, developmental, and neurological respiratory disorders, GER, and inflammatory diseases. It is observed in 25–45 % of developing children and even more with developmental disorders
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sperandio M, et al. Diffuse esophageal spasm: not diffuse but distal esophageal spasm (DES). Dig Dis Sci. 2003;48(7):1380–4.
Smout AJ. Advances in esophageal motor disorder. Curr Opin Gastroenterol. 2008;24:285–9.
Tutuian R, Castell DO. Review article: oesophageal spasm-diagnosis and management. Aliment Pharmacol Ther. 2006;23(10):1393–402.
Fontan JP, et al. Esophageal spasm associated with apnea and bradycardia in an infant. Pediatrics. 1984;73(1):52–5.
Glassman MS, et al. Spectrum of esophageal disorders in children with chest pain. Dig Dis Sci. 1992;37(5):663–6.
Rosen J, et al. Diffuse esophageal spasm in children. J Pediatr Gastroenterol Nutr. 2005;41(4):561.
Burmeister S. Review of current diagnosis and management of diffuse esophageal spasm, nutcracker esophagus/spastic nutcracker and hypertensive lower esophageal sphincter. Curr Opin Otolaryngol Head Neck Surg. 2013;21(6):543–7.
Kahrilas PJ, International High Resolution Manometry Working Group, et al. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27(2):160–74.
Singendonk MM, et al. Applying the Chicago Classification criteria of esophageal motility to a pediatric cohort: effects of patient age and size. Neurogastroenterol Motil. 2014;26(9):1333–41.
Pandolfino JE, et al. High-resolution manometry in clinical practice: utilizing pressure topography to classify oesophageal motility abnormalities. Neurogastroenterol Motil. 2009;21:796–806.
Agrawal A, et al. Clinical relevance of the nutcracker oesophagus: suggested revision of criteria for diagnosis. J Clin Gastroenterol. 2006;40:504.
Sperandio Adler DG, Romero Y. Primary esophageal motility disorders. Mayo Clin Proc. 2001;76(2):195–200.
Summerton SL. Radiographic evaluation of esophageal function. Gastrointest Endosc Clin N Am. 2005;15(2):231–42.
Grubel C, et al. Diffuse esophageal spasm. Am J Gastroenterol. 2008;103:450–7.
Hussain SZ, et al. Motility disorders: diagnosis and treatment for the pediatric patient. Pediatr Gastroenterol Nutr. 2002;49(1):27–51.
Millan MS, et al. Transition from diffuse esophageal spasm to achalasia. J Clin Gastroenterol. 1979;1:107–17.
Longstreth GF, Foroozan P. Evolution of symptomatic diffuse esophageal spasm to achalasia. South Med J. 1982;75:217–20.
Usai SP, et al. Extrinsic autonomic neuropathy in a case of transition from diffuse esophageal spasm to achalasia. Clin Auton Res. 2004;14:270–2.
Murray JA, et al. The effects of recombinant human hemoglobin on esophageal motor functions in humans. Gastroenterology. 1995;109:1241–8.
Konturek JW, et al. Diffuse esophageal spasm: a malfunction that involves nitric oxide? Scand J Gastroenterol. 1995;30:1041–5.
Mittal RK, et al. Sensory and motor function of the esophagus: lessons from ultrasound imaging. Gastroenterology. 2005;128:487–97.
Behar J, Biancani P. Pathogenesis of simultaneous esophageal contractions in patients with motility disorders. Gastroenterology. 1993;105:111–8.
Ghosh SK, et al. Quantifying esophageal peristalsis with high resolution manometry: a study of 75 asymptomatic volunteers. Am J Physiol. 2006;290:G988.
Kahrilas PJ, Sifrim D. High resolution manometry and impedance-pH/manometry: valuable tools in clinical and investigational esophagology. Gastroenterology. 2008;135:756.
Herbella FAM, et al. Primary versus secondary esophageal motility disorders: diagnosis and implications for treatment. J Laparoendosc Adv Surg Tech A. 2009;19(2):195–8.
Allen ML, DiMarino AJ. Manometric diagnosis of diffuse esophageal spasm. Dig Dis Sci. 1996;41(7):1346–9.
Lacy BE, Weiser K. Esophageal motility disorders: medical therapy. J Clin Gastroenterol. 2008;2(5):652–8.
Cannon RO, et al. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med. 1984;330:1411.
Vanuytsel T, et al. Botulinum toxin reduces dysphagia in patients with nonachalasia primary esophageal motility disorders. Clin Gastroenterol Hepatol. 2013;11(9):1115–21.
Furuta GT, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007;133:1342–63.
Potter JW, et al. Eosinophilic esophagitis in adults: an emerging problem with unique esophageal features. Gastrointest Endosc. 2004;59:355–61.
Attwood S, et al. Esophageal eosinophilia with dysphagia: a distinct clinicopathologic syndrome. Dig Dis Sci. 1993;38:109–16.
Cheung KM, et al. Esophageal eosinophilia in children with dysphagia. J Pediatr Gastroenterol Nutr. 2003;37:498–503.
Croese J, et al. Clinical and endoscopic features of eosinophilic esophagitis in adults. Gastrointest Endosc. 2003;58:516–22.
Remedios M, et al. Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate. Gastrointest Endosc. 2006;63:3–12.
Kaplan M, et al. Endoscopy in eosinophilic esophagitis: “feline” esophagus and perforation risk. Clin Gastroenterol Hepatol. 2003;1:433–7.
Lim JR, et al. White specks in the esophageal mucosa: an endoscopic manifestation of non-reflux eosinophilic esophagitis in children. Gastrointest Endosc. 2004;59:835–8.
Morrow JB, et al. The ringed esophagus: histological features of GERD. Am J Gastroenterol. 2001;96:984–9.
Noel RJ, et al. Eosinophilic esophagitis. N Engl J Med. 2004;351:940–1.
Dellon ES, et al. Prevalence of eosinophilic esophagitis in the United States. Clin Gastroenterol Hepatol. 2014;12:589–96.
Markowitz JE, Liacouras CA. Eosinophilic esophagitis. Gastroenterol Clin North Am. 2003;32:949–66.
Rothenberg ME. Biology and treatment of eosinophilic esophagitis. Gastroenterology. 2009;137:1238–49.
Nurko S, Rosen R. Esophageal dysmotility in patients who have eosinophilic esophagitis. Gastrointest Endosc Clin N Am. 2008;18:73–89.
Xu X, et al. Mast cells and eosinophils have a potential profibrogenic role in Crohn Disease. Scand J Gastroenterol. 2004;39:440–7.
Nurko S, et al. Esophageal dysmotility in children with eosinophilic esophagitis: a study using prolonged esophageal manometry. Am J Gastroenterol. 2009;104:3050–7.
Straumann A. The natural history and complications of eosinophilic esophagitis. Gastrointest Endosc Clin N Am. 2008;18(1):99–118.
Furuta GT, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007;133:1342–63.
Straumann A, et al. Pediatric and adult eosinophilic esophagitis: similarities and differences. Allergy. 2012;67:477–90.
Shah A, Hirano I. Treatment of eosinophilic esophagitis: drugs, diet, or dilation? Curr Gastroenterol Rep. 2007;9:181–8.
Liacouras CA, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128:3–20.
Schoepfer AM, et al. Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation, in a time-dependent manner. Gastroenterology. 2013;145(6):1230–6.e1–2.
Fox VL, et al. Eosinophilic esophagitis: it’s not just kid’s stuff. Gastrointest Endosc. 2002;56(2):260–70.
Straumann A, et al. Idiopathic eosinophilic esophagitis is associated with a T-helper-2-type allergic inflammatory response. J Allergy Clin Immunol. 2001;108:954–61.
Liacouras CA, et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol. 2005;3:1198–206.
Aceves SS, et al. Esophageal remodeling in pediatric eosinophilic esophagitis. J Allergy Clin Immunol. 2007;119:206–12.
Aceves SS, et al. Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-beta1, and increase esophageal smooth muscle contraction. J Allergy Clin Immunol. 2010;126:1198–204.
Mishra A, et al. Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia. Gastroenterology. 2008;134:204–14.
Zuo L, et al. IL-13 induces esophageal remodeling and gene expression by an eosinophil-independent, IL-13R alpha 2-inhibited pathway. J Immunol. 2010;185:660–9.
Glassman MS, et al. Spectrum of esophageal disorders in children with chest pain. Dig Dis Sci. 1992;37(5):663–6.
Aceves SS, Ackerman SJ. Relationships between eosinophilic inflammation, tissue remodeling, and fibrosis in eosinophilic esophagitis. Immunol Allergy Clin North Am. 2009;29:197–211.
Aceves SS. Remodeling and fibrosis in chronic eosinophil inflammation. Dig Dis. 2014;32:15–21.
Kwiatek MA, et al. Mechanical properties of the esophagus in eosinophilic esophagitis. Gastroenterology. 2011;140:82–90.
Murch SH, et al. Potential for improving therapy and defining new research targets in eosinophilic oesophagitis based on understanding of immunopathogenesis. J Pediatr Gastroenterol Nutr. 2013;57:529–34.
Korsapati H, et al. Dysfunction of the longitudinal muscles of the oesophagus in eosinophilic oesophagitis. Gut. 2009;58:1056–62.
Nennstiel S, et al. High-resolution manometry in patients with eosinophilic esophagitis under topical steroid therapy-a prospective observational study (HIMEOS-study). Neurogastroenterol Motil. 2016;28(4):599–607.
Martín ML, et al. Esophageal motor abnormalities in eosinophilic esophagitis identified by high-resolution manometry. J Gastroenterol Hepatol. 2011;26(9):1447–50.
van Rhijn BD, et al. Prevalence of esophageal motility abnormalities increases with longer disease duration in adult patients with eosinophilic esophagitis. Neurogastroenterol Motil. 2014;26(9):1349–55.
Rossi P, et al. Prolonged intra-esophageal ph profile and esophageal motility in children with eosinophilic esophagitis (EoE). J Pediatr Gastroenterol Nutr. 2015;61(4):524–5.
Roman S, et al. Manometric features of eosinophilic esophagitis in esophageal pressure topography. Neurogastroenterol Motil. 2011;23(3):208–14.
Lin Z, et al. Functional luminal imaging probe topography: an improved method for characterizing esophageal distensibility in eosinophilic esophagitis. Therap Adv Gastroenterol. 2013;6(2):97–107.
Nicodeme F, et al. Esophageal distensibility as a measure of disease severity in patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2013;11(9):1101–7.
Aceves SS, et al. Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children. Am J Gastroenterol. 2007;102(10):2271–9.
Ntoumazios SK, et al. Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem. Semin Arthritis Rheum. 2006;36:173–81.
Duraj V, et al. Esophageal damages in systemic scleroderma. Med Arch. 2007;61(1):47–8.
Vancheeswaran R, et al. Childhood-onset scleroderma: is it different from adult-onset disease? Arthritis Rheum. 1996;39(6):1041–9.
Denton CP, Derrett-Smith EC. Juvenile-onset systemic sclerosis: children are not small adults. Rheumatology. 2008;48:96–7.
Foeldvari I, et al. Favourable outcome in 135 children with juvenile systemic sclerosis: results of a multi-national survey. Rheumatology. 2000;39:556–9.
Weber P, et al. Twenty-four hour intraesophageal pH monitoring in children and adolescents with scleroderma and mixed connective tissue disease. J Rheumatol. 2000;27(11):2692–5.
Gunawardena H, McHugh N. Features and recommended treatment of systemic sclerosis. Prescriber. 2008;19(18):56–65.
Hedrich CM, et al. Presentations and treatment of childhood scleroderma: localized scleroderma, eosinophilic fasciitis, systemic sclerosis, and graft-versus-host disease. Clin Pediatr (Phila). 2011;50:604–14.
Pikarksky A, et al. Immunosuppressants and operation in ulcerative colitis. J Am Coll Surg. 2002;195(2):251–60.
Pendse S, et al. Strategies for preservation of ovarian and testicular function after immunosuppression. Am J Kidney Dis. 2004;43(5):772–81.
Janssen NM, Genta MS. The effects of immunosuppresive and anti-inflammatory medications on fertility, pregnancy, and lactation. Arch Intern Med. 2000;160(5):610–9.
Domsic R, et al. Gastrointestinal manifestations of systemic sclerosis. Dig Dis Sci. 2008;53:1163–74.
Antonucci A, et al. Chronic intestinal pseudo-obstruction. World J Gastroenterol. 2008;14(19):2953–61.
Byrne WJ, et al. Chronic idiopathic intestinal pseudo-obstruction syndrome in children: clinical characteristics and prognosis. J Pediatr. 1977;90(4):585–9.
Panganamamula KV, Parkman HP. Chronic pseudo-obstruction. Curr Treat Options Gastroenterol. 2005;8:3–11.
de Lorijn F, et al. Symptomatology, pathophysiology, diagnostic work-up, and treatment of Hirschsprung disease in infancy and childhood. Curr Gastroenterol Rep. 2007;9:245–53.
Staiano A, et al. Esophageal motility in children with Hirschsprung’s disease. Am J Dis Child. 1991;145:310–3.
Medhus AW, et al. Motility of the oesophagus and small bowel in adults treated for Hirschsprung’s disease during early childhood. Neurogastroenterol Motil. 2010;22(2):154–60. e49.
Karagiozoglou-Lampoudi T, et al. Conservative management of caustic substance ingestion in a pediatric department setting, short-term and long-term outcome. Dis Esophagus. 2010;2(42):86–91.
Sanchez-Ramirez CA, et al. Caustic ingestion and oesophageal damage in children: clinical spectrum and feeding practices. J Pediatr Child Health. 2011;47(6):378–80.
Dantas RO, Mamede RC. Esophageal motility in patients with esophageal caustic injury. Am J Gastroenterol. 1996;91(6):1157–61.
Bautista A, et al. Motor function of the esophagus after caustic burn. Eur J Pediatr Surg. 1996;6:204–7.
Genç A, Mutaf O. Esophageal motility changes in acute and late periods of caustic esophageal burns and their relation to prognosis in children. J Pediatr Surg. 2002;37(11):1526–8.
Spechler SJ, Castel D. Classification of oesophageal motility abnormalities. Gut. 2001;49:145–51.
Tutuian R, Castell DO. Clarification of the esophageal function defect in patients with manometric ineffective esophageal motility: studies using combined impedance-manometry. Clin Gastroenterol Hepatol. 2004;2:230–6.
Blonski W, et al. Revised criterion for diagnosis of ineffective esophageal motility is associated with more frequent dysphagia and greater bolus transit abnormalities. Am J Gastroenterol. 2008;103:699–704.
Kahrilas PJ, International High Resolution Manometry Working Group, et al. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27(2):160–74.
Conchillo JM, et al. Multichannel intraluminal impedance monitoring in the evaluation of patients with non-obstructive Dysphagia. Am J Gastroenterol. 2005;100(12):2624–32.
Boland K, et al. Characteristics of consecutive esophageal motility diagnoses after a decade of change. J Clin Gastroenterol. 2016;50(4):301–6.
Abdel Jalil AA, Castell DO. Ineffective Esophageal Motility (IEM): the Old-New Frontier in Esophagology. Curr Gastroenterol Rep. 2015;18(1):1.
Blonski W, et al. Revised criterion for diagnosis of ineffective esophageal motility is associated with more frequent dysphagia and greater bolus transit abnormalities. Am J Gastroenterol. 2008;103(3):699–704.
Hasenstab KA, Jadcherla SR. Respiratory events in infants presenting with apparent life threatening events: is there an explanation from esophageal motility? J Pediatr. 2014;165(2):250–5.
Savarino E, et al. Esophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-esophageal reflux disease. Aliment Pharmacol Ther. 2011;34:476–86.
Lee J, et al. Effects of age on the gastroesophageal junction, esophageal motility, and reflux disease. Clin Gastroenterol Hepatol. 2007;5:1392–8.
Wu JC, et al. Distinct clinical characteristics between patients with non-erosive reflux disease and those with reflux esophagitis. Clin Gastroenterol Hepatol. 2007;5:690–5.
Leite LP, et al. Ineffective esophageal motility (IEM): the primary finding in patients with nonspecific esophageal motility disorder. Dig Dis Sci. 1997;42(9):1859–65.
Naftali T, et al. Nonspecific esophageal motility disorders may be an early stage of a specific disorder, particularly achalasia. Dis Esophagus. 2009;22:611–5.
Müller M, et al. Clinical and manometric course of nonspecific esophageal motility disorders. Dig Dis Sci. 2012;57(3):683–9.
Rosario JA, et al. Nonspecific esophageal motility disorders in children without gastroesophageal reflux. J Pediatr Gastroenterol Nutr. 1999;28(5):480–5.
Arif T, et al. Assessment of esophageal involvement in systemic sclerosis and morphea (localized scleroderma) by clinical, endoscopic, manometric and pH metric features: a prospective comparative hospital based study. BMC Gastroenterol. 2015;15(15):24.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Mousa, H. (2017). Other Esophageal Motility Disorders. In: Faure, C., Thapar, N., Di Lorenzo, C. (eds) Pediatric Neurogastroenterology. Springer, Cham. https://doi.org/10.1007/978-3-319-43268-7_22
Download citation
DOI: https://doi.org/10.1007/978-3-319-43268-7_22
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43266-3
Online ISBN: 978-3-319-43268-7
eBook Packages: MedicineMedicine (R0)